Table 2.
Patient Characteristics and Medication Use at Trial Entry
| No. enrolled | 119 |
| No. completing 12 weeks follow up (Male/Female) | 103 (60/43) |
| Median age years (range) | 57 (28–78) |
| Mean weight kilograms (range) | 81 (49–135) |
| Mean Body Mass Index (kg/m2) | 30.3 |
| Mean fasting glucose mg/dL (range) | 211 (107–513) |
| Mean Hemoglobin A1c % (range) | 9 (6–17) |
| Mean total cholesterol mg/dL (range) | 212 (100–706) |
| Mean triglyceride mg/dL (range) | 266 (151–1520) |
| Insulin use no. (% of total patients) | 13 (12.6%) |
| Sulphonylurea use no. (% of total) | 19 (18.4%) |
| Biguanide use no. (% of total) | 44(42.7%) |
| Meglitinide uses no. (% of total) | 2 (1.94%) |
| Combination oral hypoglycemic use no. (% of total) | 25 (24.3%) |
| Antihypertensive medications % of total | 38% |
| Anti-lipid medication (statins and fibrates) % of total | 45% |
mg/dL = milligrams per deciliter. kg/m2 = kilograms per square meter.